Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
patient death
Biotech
Analysts unshaken by patient death in BMS lung fibrosis trial
Analysts were quick to dismiss concerns that the liver toxicity seen with BMS' admilparant spell larger trouble for the LPA1 drug class.
Darren Incorvaia
Oct 1, 2026 10:22am
After 2 undisclosed deaths, can China’s IIT still be trusted?
Aug 17, 2026 7:20am
FDA issues alert in wake of BD recall of faulty needle sets
Aug 10, 2026 8:12am
FDA hits Newron schizophrenia ph. 3 trial with hold after death
Apr 29, 2026 2:50pm
FDA freezes enrollment in MacroGenics cancer trial after death
Feb 24, 2026 2:00pm
FDA frees Intellia of 1 clinical hold for CRISPR therapy
Jan 27, 2026 10:54am
